Dr Arijit Bishnu is the best haemato- onchologist in Siliguri, with great skills and friendly nature.
Comprehensive support focused on quality of life for patients with serious hematologic conditions. Palliative care in hematology is a specialized approach that focuses on relieving symptoms, managing complications, and improving emotional, psychological, and spiritual well-being in patients with blood disorders—whether malignant or non-malignant. It is not limited to end-of-life care but can be integrated early in the treatment process alongside curative or disease-controlling therapies. Patients with conditions like leukemia, lymphoma, myeloma, myelofibrosis, or advanced marrow failure syndromes often face intense treatments and chronic symptoms. Palliative care helps manage these challenges by addressing pain, fatigue, breathing difficulties, infections, anxiety, and treatment-related side effects.
The care is provided by a multidisciplinary team, including hematologists, palliative medicine specialists, nurses, social workers, and chaplains. This comprehensive support extends to caregivers, offering them guidance, education, and emotional assistance. Palliative care, when integrated early, enhances the overall experience by focusing on comfort, dignity, and informed decision-making, ensuring patients and their families receive the support they need through each stage of the illness.
Dr. Arijit Bishnu and his team use advanced diagnostics, such as genetic testing and molecular profiling, to determine whether targeted therapy is right for a patient. Treatment is then closely monitored and adjusted based on response and tolerance :
Medical History Review: Understanding your symptoms, lifestyle, and medical history to assess any underlying conditions that may be contributing to the menstrual issues.
Treatment of specific blood cancers - Used in conditions such as chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), certain lymphomas, and myeloproliferative neoplasms.
Molecular targeting - Focuses on proteins, genes, or cellular pathways that drive abnormal blood cell growth or survival.
Genetic testing required -Requires molecular diagnostics to identify the presence of targetable mutations or markers.
Fewer side effects than chemotherapy - Typically spares normal cells, leading to lower risk of hair loss, nausea, or widespread immune suppression.
Key advancement in personalized medicine - Allows hematologists to match treatment to each patient’s unique disease profile for optimal outcomes.
© Dr. Arijit Bishnu. All Rights Reserved.
Designed by Digiex Web